Literature DB >> 14159462

THE LABORATORY CONTROL OF THROMBOLYTIC THERAPY.

C HAWKEY, M HOWELL.   

Abstract

Methods are described by which thrombolytic therapy with local and systemic infusion of streptokinase can be initiated and controlled.

Keywords:  BLOOD COAGULATION TESTS; FIBRINOGEN; FIBRINOLYSIN; PLASMINOGEN; PROTHROMBIN TIME; STREPTODORNASE AND STREPTOKINASE; THROMBOEMBOLISM

Mesh:

Substances:

Year:  1964        PMID: 14159462      PMCID: PMC480744          DOI: 10.1136/jcp.17.3.287

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  16 in total

1.  INTRAVENOUS STREPTOKINASE IN THE TREATMENT OF RETINAL VASCULAR OCCLUSION.

Authors:  C HAWKEY; M HOWELL
Journal:  J Clin Pathol       Date:  1964-05       Impact factor: 3.411

2.  A method for the comparison of the antiplasmin activity of two groups of blood sera.

Authors:  M HOWELL
Journal:  J Clin Pathol       Date:  1963-05       Impact factor: 3.411

3.  The specific assay of Prower-Stuart factor and factor VII.

Authors:  K W DENSON
Journal:  Acta Haematol       Date:  1961-02       Impact factor: 2.195

4.  Congenital factor VII deficiency: haematological and genetic aspects.

Authors:  F E DISCHE; V BENFIELD
Journal:  Acta Haematol       Date:  1959-05       Impact factor: 2.195

5.  The maintenance of a sustained thrombolytic state in man. I. Induction and effects.

Authors:  A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1959-07       Impact factor: 14.808

6.  The lysis of artificially induced intravascular clots in man by intravenous infusions of streptokinase.

Authors:  A J JOHNSON; W R McCARTY
Journal:  J Clin Invest       Date:  1959-09       Impact factor: 14.808

7.  The effect of citrate on euglobulin methods of estimating fibrinolytic activity.

Authors:  M BUCKELL
Journal:  J Clin Pathol       Date:  1958-09       Impact factor: 3.411

8.  A modification for routine laboratory use of Stefanini's method of estimating factor V activity in human oxalated plasma.

Authors:  P WOLF
Journal:  J Clin Pathol       Date:  1953-02       Impact factor: 3.411

9.  Activity of plasma labile factor in disease.

Authors:  M STEFANINI
Journal:  Lancet       Date:  1951-03-17       Impact factor: 79.321

10.  Partial purification and properties of a proteolytic enzyme of human serum.

Authors:  L F REMMERT; P P COHEN
Journal:  J Biol Chem       Date:  1949-11       Impact factor: 5.157

View more
  3 in total

Review 1.  THE FIBRINOLYTIC MECHANISM IN HAEMOSTASIS: A REVIEW.

Authors:  J L STAFFORD
Journal:  J Clin Pathol       Date:  1964-09       Impact factor: 3.411

2.  ARTERIAL OCCLUSION TREATED WITH STREPTOKINASE. A REPORT OF TWO CASES.

Authors:  M L CLARK; M HOWELL; C HAWKEY; R S REES; J STUBBS
Journal:  Postgrad Med J       Date:  1965-02       Impact factor: 2.401

3.  Neutralising antibodies after streptokinase treatment for myocardial infarction: a persisting puzzle.

Authors:  K McGrath; C Hogan; D Hunt; C O'Malley; N Green; R Dauer; A Dalli
Journal:  Br Heart J       Date:  1995-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.